A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
Regeneron Pharmaceuticals
Brown University
Institut Bergonié
National Cancer Institute (NCI)
Institut Bergonié
SOLTI Breast Cancer Research Group
Tasly Biopharmaceuticals Co., Ltd.
The Methodist Hospital Research Institute
Novartis
Zhejiang Provincial People's Hospital
Duke University
MultiVir, Inc.
Stanford University